Novel platform for the preparation of synthetic orally active peptidomimetics with hemoregulating activity. II. Hemosuppressor activity of 2,5-diketopiperazine-based cyclopeptides.
Animal research · 2020
- What was studied
- The available record identifies the subject in the title but gives no verified sample details.
- Main finding
- The later platform paper studies suppressive cyclic derivatives. Opposing experimental effects do not establish a shared receptor or clinical interchangeability.
Study data at a glance
- Participants or experimental model
- See original report; human, animal and laboratory components must be distinguished.
- Reported results
- The later platform paper studies suppressive cyclic derivatives. Opposing experimental effects do not establish a shared receptor or clinical interchangeability.
Study limitations and source details
Study limitations
- The abstract leaves the preparation and study methods unclear.
- Related publications may share experiments; source count is not independent-study count.
Source details
Indexed metadata and abstract checked via Europe PMC. Original full methods not reviewed.
Sources checked
Citation
Deigin V, Ksenofontova O, Yatskin O, Goryacheva A, Ignatova A, Feofanov A, Ivanov V.. Novel platform for the preparation of synthetic orally active peptidomimetics with hemoregulating activity. II. Hemosuppressor activity of 2,5-diketopiperazine-based cyclopeptides. International immunopharmacology
Study source ↗ · DOI 10.1016/j.intimp.2020.106185 · Bibliography entry · Link to this summary